Should long-acting β2-agonists be considered an alternative first choice option for the treatment of stable COPD?

被引：15

作者：

Cazzola, M

Matera, MG

机构：

[1] S Maugen Fdn, Inst Care & Res, Med Ctr Rehabil, Clin Pharmacol Unit, Veruno, NO, Italy

[2] S Maugen Fdn, Inst Care & Res, Med Ctr Rehabil, Resp Pharmacol Ctr, Veruno, NO, Italy

来源：

RESPIRATORY MEDICINE | 1999年 / 93卷 / 04期

关键词：

D O I：

10.1016/S0954-6111(99)90017-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：227 / 229

页数：3

共 21 条

[1]

*AM THOR SOC, 1995, AM J RESP CRIT CARE, V152, pS72

[2]

ANDERSON W, 1997, AM J RESP CRIT CARE, V155, pA278

[3]

BAILEY W, 1997, AM J RESP CRIT CARE, V155, pA278

[4]

BONE R, 1994, CHEST, V105, P1411

[5]

Boyd G, 1997, EUR RESPIR J, V10, P815

[6] Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia [J].

Cazzola, M ;

Imperatore, F ;

Salzillo, A ;

Di Perna, F ;

Calderaro, F ;

Imperatore, A ;

Matera, MG .

CHEST, 1998, 114 (02) :411-415

[7] A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease [J].

Cazzola, M ;

Matera, MG ;

Di Perna, F ;

Calderaro, F ;

Califano, C ;

Vinciguerra, A .

RESPIRATORY MEDICINE, 1998, 92 (02) :354-357

[8] The use of bronchodilators in stable chronic obstructive pulmonary disease [J].

Cazzola, M ;

Spina, D ;

Matera, MG .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 1997, 10 (03) :129-144

[9] Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease [J].

Cazzola, M ;

Vinciguerra, A ;

Di Perna, F ;

Matera, MG .

RESPIRATORY MEDICINE, 1998, 92 (08) :1012-1016

[10] Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD [J].

Cazzola, M ;

Di Perna, F ;

Noschese, P ;

Vinciguerra, A ;

Calderaro, F ;

Girbino, G ;

Matera, MG .

EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (06) :1337-1341

← 1 2 3 →